NRIX

aiSwingX™ analyzes US filings and reports them as news investors can read.
–
0 2

Filings EDGAR acceptance time · auto bulletin · source link

FiledFormPeriodAuto flagsCite
2h 15m after EDGAR10-QQ3 2026 · 2026-08-31 Subscribersfacts →

Numbers to watch every quarter

Metric2025Q3 free2026Q3
Accounts receivable
10-Q 2026Q3 balance sheet
Capex (YTD)
10-Q 2026Q3 statement of cash flows
Cash
10-Q 2026Q3 balance sheet
Net income
10-Q 2026Q3 statement of income (comparative)
-86.4$M
Operating cash flow (YTD)
10-Q 2026Q3 statement of cash flows (comparative)
-181.6$M
Operating income
10-Q 2026Q3 statement of income (comparative)
-91.4$M
Revenue
10-Q 2026Q3 statement of income (comparative)
7.9$M
Stock-based compensation (YTD)
10-Q 2026Q3 statement of cash flows
Total equity
10-Q 2026Q3 balance sheet

One quarter of figures is open; the other quarters, including the one the latest article covers, are for subscribers. See plans

2026Q3 · 10-Q ·

Nurix Therapeutics swung to a profit: net income went from −$86.4m to $549.8m

Net income went from −$86.4m in the same period a year earlier to $549.8m.
aiSwingX™ analyzes US filings and reports them as news investors can read.
–
0 2